johnson & johnson news

Johnson & Johnson Stock Rises on Better-Than-Expected Revenue, Adjusted Profit

Key Takeaways Johnson & Johnson shares advanced Tuesday after the pharmaceutical and medical device company posted better third-quarter sales and adjusted profit than expected.Net income fell sharply due to billions in one-time expenses like legal costs.

MarketWatch · 1d

Johnson & Johnson's stock set to rise, lifted by Q3 results

Johnson & Johnson's stock was up in premarket trades Tuesday after the drugmaker reported better-than-expected third-quarter sales and raised full-year revenue guidance.

SFGate · 1d

Johnson & Johnson: Q3 Earnings Snapshot

The average estimate of seven analysts surveyed by Zacks Investment Research was for earnings of $2.22 per share. The world's biggest maker of health care products posted revenue of $22.47 billion in the period,

Jets owner Woody Johnson is optimistic at 2-4

Jets Wire · 8h

Jets owner Woody Johnson is optimistic at 2-4: 'We’re going to kick…'

There’s proof in the pudding and words when it comes to Jets owner Woody Johnson. Johnson spoke at the NFL owners’ meetings on Tuesday. That happened shortly after the Jets traded for All-Pro receiver Davante Adams.

Bleacher Report · 1d

Jets' Woody Johnson Talks Davante Adams Trade, Says 'Status Quo' Won't Lead to Wins

New York Jets owner Woody Johnson didn't mince words about the team's desire to win in the wake of Tuesday's deal to acquire Davante Adams from the Las

NBC Sports on MSN · 1d

Woody Johnson: Jets want to bring a lot of change this week

Jets owner Woody Johnson is eager to see his team win, and win this year. Johnson spoke to reporters at the league meeting shortly after news broke that the Jets will be acquiring wide receiver Davante Adams in a trade with the Raiders,

Springfield businessman, arts leader awarded $15M from Johnson & Johnson in body talc suit

Evan C. Plotkin, an artist and father of three, was diagnosed in 2021 with mesothelioma, a cancer of the lining of the lungs ...

1don MSN

Johnson & Johnson’s stock falls despite Q3 sales beat and guidance raise

Johnson & Johnson reported better-than-expected third-quarter sales and raised its full-year revenue guidance.

Johnson & Johnson's MedTech Challenges Loom Amid Chinese Market Pressures And Orthopedics Overhaul, Analysts Say

Johnson & Johnson's Q3 2024 results surpassed analyst expectations, reporting $2.42 EPS and $22.47 billion in sales. Updated ...

FiercePharma3h

Johnson & Johnson sets 'new standard in inclusive marketing' with diverse Tremfya psoriasis ad

Though psoriasis affects people of all skin tones, that diversity isn’t always represented in portrayals of the condition in ...

13hon MSN

Johnson & Johnson Beats Wall Street Estimates. Is It Time to Buy, Sell, or Hold?

Third-quarter results exceeded estimates, but the company also lowered overall earnings expectations for 2024.

Johnson & Johnson Q3: Strengthening Cardiovascular Device Portfolio

Johnson & Johnson's Q3 results exceeded expectations, with 26.5% year-over-year growth in the cardiovascular market and a 5.4 ...

22hon MSN

Deloitte, Johnson & Johnson execs say people aren’t using their health benefits until they are in crisis

“We should all care about health equity because that is one more person who is going to have a challenge to care for their ...

4hon MSN

Michigan football DB Will Johnson 'definitely disappointed' with secondary

Naturally, much of the near 10-minute discussion was focused on the defense and its struggles. Just one year after leading ...

Pirates' Termarr Johnson Stacks Another Hit in AFL

It was a relatively quiet day for Pittsburgh Pirates No. 3 prospect Termarr Johnson in his return to the lineup in the ...

22mon MSN

David Johnson Joins the Grizzlies

Following Scotty Pippen Jr.’s promotion to a four-year contract, the Memphis Grizzlies announced the signing of guard David ...

Johnson & Johnson’s Growth Potential Highlighted by Strong Q3 Earnings and Promising Pipeline

David Risinger, an analyst from Leerink Partners, maintained the Buy rating on Johnson & Johnson (JNJ – Research Report). The ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Related topics